Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial (vol 106, pg 444, 2017)

被引：0

作者：

Filippatos, Gerasimos ^{[1
,15
]}

Farmakis, Dimitrios ^{[1
]}

Metra, Marco ^{[2
]}

Cotter, Gad ^{[3
]}

Davison, Beth A. ^{[3
]}

Felker, G. Michael ^{[4
]}

Greenberg, Barry H. ^{[5
]}

Hua, Tsushung A. ^{[6
]}

Pang, Peter S. ^{[7
,8
]}

Ponikowski, Piotr ^{[9
]}

Qian, Min ^{[10
]}

Severin, Thomas A. ^{[11
]}

Voors, Adriaan A. ^{[12
]}

Teerlink, John R. ^{[13
,14
]}

机构：

[1] Univ Athens, Sch Med, Athens, Greece

[2] Univ Brescia, Brescia, Italy

[3] Momentum Res Inc, Durham, NC USA

[4] Duke Clin Res Inst, Durham, NC USA

[5] Univ Calif San Diego, San Diego, CA 92103 USA

[6] Novartis Pharmaceut, New Hanover, NJ USA

[7] Indiana Univ Sch Med, Indianapolis, IN 46202 USA

[8] Regenstrief Inst Hlth Care, Indianapolis, IN USA

[9] Med Univ, Clin Mil Hosp, Wroclaw, Poland

[10] Columbia Univ, New York, NY USA

[11] Novartis Pharma AG, Basel, Switzerland

[12] Univ Groningen, Groningen, Netherlands

[13] Univ Calif San Francisco, San Francisco, CA 94143 USA

[14] San Francisco VA Med Ctr, San Francisco, CA USA

[15] Athens Univ Hosp Attikon, Dept Cardiol, Heart Failure Unit, 1 Rimini St, Athens 12462, Greece

来源：

CLINICAL RESEARCH IN CARDIOLOGY | 2017年 / 106卷 / 11期

关键词：

D O I：

10.1007/s00392-017-1139-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：938 / 938

页数：1

共 50 条

[21] Hepatorenal dysfunction identifies high-risk patients with acute heart failure: insights from the RELAX-AHF trial
Biegus, Jan
Demissei, Biniyam
Postmus, Douwe
Cotter, Gad
Davison, Beth A.
Feker, G. Michael
Filippatos, Gerasimos
Gimpelewicz, Claudio
Greenberg, Barry
Metra, Marco
Severin, Thomas
Teerlink, John R.
Voors, Adriaan A.
Ponikowski, Piotr
ESC HEART FAILURE, 2019, 6 (06): : 1188 - 1198
[22] Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients Admitted for Acute Heart Failure (As Seen in the BLAST-AHF, Pre-RELAX-AHF, and RELAX-AHF Studies)
Davison, Beth A.
Takagi, Koji
Edwards, Christopher
Adams, Kirkwood F.
Butler, Javed
Collins, Sean P.
Dorobantu, Maria I.
Ezekowitz, Justin A.
Filippatos, Gerasimos
Greenberg, Barry H.
Levy, Phillip D.
Masip, Josep
Metra, Marco
Pang, Peter S.
Ponikowski, Piotr
Severin, Thomas M.
Teerlink, John R.
Teichman, Sam L.
Voors, Adriaan A.
Werdan, Karl
Cotter, Gad
AMERICAN JOURNAL OF CARDIOLOGY, 2022, 180 : 72 - 80
[23] Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome-an analysis from RELAX-AHF
Voors, Adriaan A.
Davison, Beth A.
Teerlink, John R.
Felker, G. Michael
Cotter, Gad
Filippatos, Gerasimos
Greenberg, Barry H.
Pang, Peter S.
Levin, Bruce
Hua, Tsushung A.
Severin, Thomas
Ponikowski, Piotr
Metra, Marco
EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (11) : 1230 - 1240
[24] The Efficacy, Safety, and Tolerability of Additional Serelaxin Administration to Standard Therapy in Asian Patients with Acute Heart Failure: The RELAX-AHF-ASIA trial
Sato, Naoki
Lam, Carolyn S. P.
Teer-Link, John R.
Greenberg, Barry H.
Tsutsui, Hiroyuki
Oh, Byung-Hee
Zhang, Jian
Hua, Tsushung A.
Wang, Xing Li
Ge, Jumbo
JOURNAL OF CARDIAC FAILURE, 2018, 24 (11) : 812 - 812
[25] Worse prognosis of real-world patients with acute heart failure from the Czech AHEAD registry in comparison to patients from the RELAX-AHF trial
Spinar, Jindrich
Jarkovsky, Jiri
Spinarova, Lenka
Vitovec, Jiri
Linhart, Ales
Widimsky, Petr
Miklik, Roman
Zeman, Kamil
Belohlavek, Jan
Malek, Filip
Cihalik, Cestmir
Spac, Jiri
Felsoci, Marian
Ostadal, Petr
Dusek, Ladislav
Kettner, Jiri
Vaclavik, Jan
Littnerova, Simona
Monhart, Zdenek
Malek, Josef
Parenica, Jiri
ESC HEART FAILURE, 2017, 4 (01): : 8 - 15
[26] Evaluating the efficacy, safety and tolerability of serelaxin when added to standard therapy in asian patients with acute heart failure: The RELAX-AHF-ASIA trial
Sato, N.
Lam, C. S.
Teerlink, J. R.
Greenberg, B. H.
Tsutsui, H.
Oh, B. H.
Zhang, J.
Hua, T. A.
Wang, X. L.
Ge, J.
EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 41 - 41
[27] A multi-time-point based multimarker risk stratification strategy in acute heart failure - results from the RELAX-AHF trial
Demissei, B.
Cotter, G.
Prescott, M. F.
Felker, G. M.
Filippatos, G.
Greenberg, B. H.
Pang, P. S.
Ponikowski, P.
Severin, T. M.
Wang, Y. L.
Qian, M.
Teerlink, J. R.
Metra, M.
Davison, B. A.
Voors, A. A.
EUROPEAN HEART JOURNAL, 2016, 37 : 442 - 442
[28] Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes An Exploratory Analysis From the RELAX-AHF Trial
Pang, Peter S.
Teerlink, John R.
Voors, Adriaan A.
Ponikowski, Piotr
Greenberg, Barry H.
Filippatos, Gerasimos
Felker, G. Michael
Davison, Beth A.
Cotter, Gad
Kriger, Joshua
Prescott, Margaret F.
Hua, Tsushung A.
Severin, Thomas
Metra, Marco
JACC-HEART FAILURE, 2016, 4 (07) : 591 - 599
[29] Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study
Cotter, Gad
Voors, Adriaan A.
Prescott, Margaret F.
Felker, G. Michael
Filippatos, Gerasimos
Greenberg, Barry H.
Pang, Peter S.
Ponikowski, Piotr
Milo, Olga
Hua, Tsushung A.
Qian, Min
Severin, Thomas M.
Teerlink, John R.
Metra, Marco
Davison, Beth A.
EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (11) : 1133 - 1143
[30] A Low baseline hsTnT value in acute heart failure identifies patients at very low risk for 180-day cardiovascular mortality: An analysis from the RELAX-AHF trial
Pang, P.
Metra, M.
Prescott, M. F.
Ponikowski, P.
Kriger, J.
Greenberg, B.
Filippatos, G.
Felker, M.
Davison, B.
Teerlink, J. R.
EUROPEAN HEART JOURNAL, 2015, 36 : 1199 - 1199

← 1 2 3 4 5 →